OpenAI 收购 Orchestra Bio，加码生命科学领域
精选理由
OpenAI 把 Orchestra Bio 收进来了，打算和它的 Rosalind 生命科学工具打通，帮药企加快新药上市流程。
OpenAI 宣布收购 Orchestra Bio，该平台帮助生物制药团队协调药物开发的复杂流程。收购后将与 Rosalind（OpenAI 面向生命科学研究的 AI 模型与工具）结合，优化药物研发运营。OpenAI 未披露本次交易金额。
原文 · OpenAI
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! openai.com/index/openai-t… 💬 121 🔄 105 ❤️ 1305 👀 79123 📊 240 ⚡
